In conclusion, the activated PBX2‐PRMT1‐SWI/SNF‐IGF2BP2 signaling pathway likely plays a critical role in the progression and prognosis of HNSCC (Figure 7L). The gene discussed is SMARCA1; the disease is head and neck squamous cell carcinoma.